People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tenex Health, Inc. | — | Biotechnology | Series B | $57.4M | $1.2B | 2013 |
Julie Flanery at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Julie Flanery on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ivan Mijatovic | 1 | 2 |
| Jay Smith | 1 | 2 |
| Clay Wilemon | 1 | 1 |
| Bernard Morrey, M.D. | 1 | 1 |
| Rom Papadopoulos | 1 | 1 |
| Darryl Barnes | 1 | 1 |
| Jagi Gill | 1 | 1 |
| Rom Papodopolous | 1 | 1 |
| Tate Parham | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.